Analyst Consensus ?
ConsensusBuy36 ratings
Bullish2158.3%
Neutral1438.9%
Bearish12.8%
1 unmapped firm rating excluded from the percentages.
FN2 Earnings Intelligence
The Sherwin-Williams Company analyst ratings
The Sherwin-Williams Company (SHW) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$323.31Current
$260Low
$368.77Average
$438High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 12, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Jul 29, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jul 29, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jul 29, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Jul 29, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jul 8, 2026 |
| Citigroup | Buy | Buy | Maintain | Jun 24, 2026 |
| UBS | Neutral | Buy | Downgrade | Jun 2, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | May 8, 2026 |
| B of A Securities | Neutral | Neutral | Maintain | Apr 21, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Mar 23, 2026 |
| Loop Capital | Buy | Buy | Maintain | Jul 23, 2025 |
| Barclays | Equal Weight | Equal Weight | Maintain | Apr 1, 2025 |
| Jefferies | Hold | Buy | Downgrade | Mar 10, 2025 |
| Baird | Neutral | Neutral | Maintain | Oct 23, 2024 |
| Keybanc | Overweight | Downgrade | Oct 7, 2024 | |
| Goldman Sachs | Buy | Buy | Maintain | Jul 24, 2024 |
| Seaport Global | Neutral | Buy | Downgrade | Jan 8, 2024 |
| Northcoast Research | Neutral | Buy | Downgrade | Jan 2, 2024 |
| Argus Research | Buy | Buy | Maintain | Dec 21, 2023 |
| Berenberg | Hold | Hold | Maintain | Sep 29, 2023 |
| Deutsche Bank | Buy | Buy | Maintain | Jul 18, 2023 |
| Credit Suisse | Underperform | Underperform | Maintain | Jul 28, 2022 |
| Susquehanna | Neutral | Positive | Downgrade | Feb 5, 2020 |
| CFRA | Hold | Buy | Downgrade | Jan 30, 2020 |
| Edward Jones | Hold | Buy | Downgrade | Nov 20, 2019 |
| Buckingham Research | Neutral | Neutral | Maintain | Oct 23, 2019 |
| Buckingham | Neutral | Neutral | Maintain | Oct 23, 2019 |
| Bank of America | Buy | Buy | Maintain | Jul 25, 2018 |
| Argus | Buy | Hold | Upgrade | May 5, 2018 |
| Zelman | Buy | Hold | Upgrade | Oct 18, 2017 |
| Longbow Research | Buy | Neutral | Upgrade | Jun 13, 2017 |
| CLSA | Buy | Outperform | Maintain | Jul 22, 2016 |
| Sterne Agee CRT | Buy | Neutral | Upgrade | Aug 25, 2015 |
| Sterne Agee | Buy | Neutral | Upgrade | Aug 25, 2015 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Apr 23, 2015 |
| Nomura | Buy | Neutral | Upgrade | Apr 15, 2013 |
| Credit Agricole | Outperform | Underperform | Upgrade | Nov 13, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $323.31. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| D.A. Davidson | Analyst unavailable | $400 | $346.73 | +23.7% | Aug 24, 2026 |
| Guggenheim | Analyst unavailable | $400 | $340.85 | +23.7% | Aug 3, 2026 |
| Goldman Sachs | Duffy Fischer | $420 | $343.88 | +29.9% | Jul 29, 2026 |
| BMO Capital | Analyst unavailable | $405 | $341.42 | +25.3% | Jul 29, 2026 |
| UBS | Joshua Spector | $390 | $341.57 | +20.6% | Jul 29, 2026 |
| Wells Fargo | Analyst unavailable | $360 | $354.27 | +11.3% | Jul 29, 2026 |
| Morgan Stanley | Vicent Andrews | $395 | $354.27 | +22.2% | Jul 29, 2026 |
| Jefferies | Laurence Alexander | $375 | $354.27 | +16.0% | Jul 28, 2026 |
| Berenberg Bank | Aron Ceccarelli | $380 | $305.3 | +17.5% | Jun 8, 2026 |
| BMO Capital | Analyst unavailable | $355 | $297.49 | +9.8% | Jun 3, 2026 |
| UBS | Analyst unavailable | $330 | $294.86 | +2.1% | Jun 2, 2026 |
| Evercore ISI | Analyst unavailable | $390 | $317.6 | +20.6% | Apr 29, 2026 |
| Wells Fargo | Analyst unavailable | $365 | $335.59 | +12.9% | Apr 10, 2026 |
| Mizuho Securities | Analyst unavailable | $410 | $368.89 | +26.8% | Feb 17, 2026 |
| UBS | Analyst unavailable | $420 | $355.36 | +29.9% | Jan 30, 2026 |
| RBC Capital | Analyst unavailable | $390 | $354.58 | +20.6% | Jan 30, 2026 |
| Deutsche Bank | Analyst unavailable | $380 | $350.63 | +17.5% | Jan 22, 2026 |
| UBS | Joshua Spector | $415 | $356.34 | +28.4% | Jan 12, 2026 |
| Vertical Research | Analyst unavailable | $371 | $340.09 | +14.8% | Jan 7, 2026 |
| Mizuho Securities | Analyst unavailable | $390 | $327.95 | +20.6% | Dec 18, 2025 |
| Mizuho Securities | Analyst unavailable | $400 | $351.2 | +23.7% | Oct 29, 2025 |
| RBC Capital | Analyst unavailable | $405 | $354.45 | +25.3% | Oct 29, 2025 |
| UBS | Analyst unavailable | $422 | $351.2 | +30.5% | Oct 29, 2025 |
| Wells Fargo | Michael Sison | $410 | $354.45 | +26.8% | Oct 29, 2025 |
| Wells Fargo | Analyst unavailable | $395 | $333.22 | +22.2% | Oct 10, 2025 |
| UBS | Analyst unavailable | $400 | $338.31 | +23.7% | Oct 6, 2025 |
| Mizuho Securities | John Roberts | $395 | $336.77 | +22.2% | Apr 15, 2025 |
| Jefferies | Laurence Alexander | $380 | $363.62 | +17.5% | Mar 10, 2025 |
| Robert W. Baird | Ghansham Panjabi | $370 | $358.16 | +14.4% | Jan 31, 2025 |
| RBC Capital | Arun Viswanathan | $438 | $334.4 | +35.5% | Jan 14, 2025 |
| Mizuho Securities | John Roberts | $408 | $334.4 | +26.2% | Jan 7, 2025 |
| Jefferies | Laurence Alexander | $423 | $345.47 | +30.8% | Jan 2, 2025 |
| RBC Capital | Arun Viswanathan | $446 | $362.72 | +37.9% | Oct 24, 2024 |
| Robert W. Baird | Ghansham Panjabi | $360 | $361.38 | +11.3% | Oct 23, 2024 |
| Goldman Sachs | Duffy Fischer | $410 | $361.38 | +26.8% | Oct 23, 2024 |
| Evercore ISI | Greg Melich | $400 | $361.38 | +23.7% | Oct 23, 2024 |
| Barclays | Michael Leithead | $370 | $361.38 | +14.4% | Oct 23, 2024 |
| Jefferies | Laurence Alexander | $445 | $388.36 | +37.6% | Oct 21, 2024 |
| BMO Capital | John McNulty | $400 | $363.75 | +23.7% | Sep 3, 2024 |
| Jefferies | Laurence Alexander | $415 | $358.73 | +28.4% | Aug 26, 2024 |
| Berenberg Bank | Aron Ceccarelli | $312 | $352.55 | -3.5% | Jul 30, 2024 |
| Deutsche Bank | David Begleiter | $385 | $340 | +19.1% | Jul 24, 2024 |
| Robert W. Baird | Ghansham Panjabi | $325 | $344.5 | +0.5% | Jul 24, 2024 |
| Barclays | Michael Leithead | $355 | $344.5 | +9.8% | Jul 24, 2024 |
| UBS | Joshua Spector | $355 | $298.95 | +9.8% | Jul 9, 2024 |
| BMO Capital | John McNulty | $360 | $296 | +11.3% | Jun 11, 2024 |
| Jefferies | Laurence Alexander | $370 | $301.73 | +14.4% | May 29, 2024 |
| RBC Capital | Arun Viswanathan | $370 | $303.73 | +14.4% | Apr 25, 2024 |
| KeyBanc | Kenneth Zener | $400 | $303.73 | +23.7% | Apr 25, 2024 |
| Morgan Stanley | Vicent Andrews | $338 | $302.03 | +4.5% | Apr 23, 2024 |
| Mizuho Securities | John Roberts | $334 | $296.76 | +3.3% | Apr 23, 2024 |
| Goldman Sachs | Duffy Fischer | $348 | $296.76 | +7.6% | Apr 23, 2024 |
| BMO Capital | John McNulty | $385 | $296.76 | +19.1% | Apr 23, 2024 |
| Deutsche Bank | David Begleiter | $350 | $296.76 | +8.3% | Apr 23, 2024 |
| Evercore ISI | Greg Melich | $350 | $309.38 | +8.3% | Apr 19, 2024 |
| UBS | Analyst unavailable | $255 | $241.82 | -21.1% | Jan 11, 2023 |
| Wells Fargo | Analyst unavailable | $220 | $240.04 | -32.0% | Jan 9, 2023 |
| J.P. Morgan | Analyst unavailable | $260 | $251.24 | -19.6% | Dec 2, 2022 |
| Mizuho Securities | Analyst unavailable | $294 | $245.72 | -9.1% | Jul 14, 2022 |
| Barclays | Michael Leithead | $303 | $272.32 | -6.3% | May 2, 2022 |
| RBC Capital | Analyst unavailable | $342 | $277.21 | +5.8% | Apr 28, 2022 |
| Wells Fargo | Analyst unavailable | $285 | $279.52 | -11.8% | Apr 27, 2022 |
| Wells Fargo | Truman Patterson | $275 | $244.92 | -14.9% | Apr 24, 2022 |
| Loop Capital Markets | Garik Shmois | $300 | $261.1 | -7.2% | Apr 11, 2022 |
| Jefferies | Laurence Alexander | $275 | $244.38 | -14.9% | Mar 16, 2022 |
| Robert W. Baird | Ghansham Panjabi | $350 | $287.03 | +8.3% | Jan 28, 2022 |
| Mizuho Securities | Chris Parkinson | $350 | $287.03 | +8.3% | Jan 28, 2022 |
| BMO Capital | John McNulty | $310 | $287.03 | -4.1% | Jan 28, 2022 |
| Barclays | Duffy Fischer | $345 | $292.85 | +6.7% | Jan 22, 2022 |
| Wells Fargo | Michael Sison | $335 | $305.51 | +3.6% | Jan 18, 2022 |
| Citigroup | PJ Juvekar | $358 | $323.75 | +10.7% | Jan 11, 2022 |
| Morgan Stanley | Vincent Andrews | $375 | $323.75 | +16.0% | Jan 11, 2022 |
| Goldman Sachs | Robert Koort | $320 | $344.84 | -1.0% | Dec 15, 2021 |
| Berenberg Bank | Anthony Manning | $310 | $316.12 | -4.1% | Oct 27, 2021 |
| Wolfe Research | Truman Patterson | $325 | $285.88 | +0.5% | Jul 28, 2021 |
| Argus Research | Bill Selesky | $325 | $281.31 | +0.5% | May 4, 2021 |
Track every rating change on SHW the moment it posts. Free to start.
Start free